142 related articles for article (PubMed ID: 7736448)
1. Noncovalent binding of a mitomycin C metabolite, 2,7-diaminomitosene, to duplex DNA.
Peterson DM; Fisher J; Beall HD; Ross D
Cancer Lett; 1995 Apr; 90(2):133-8. PubMed ID: 7736448
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
Pan SS; Yu F; Hipsher C
Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C.
Suresh Kumar G; Lipman R; Cummings J; Tomasz M
Biochemistry; 1997 Nov; 36(46):14128-36. PubMed ID: 9369485
[TBL] [Abstract][Full Text] [Related]
4. Bioreductive activation of mitomycin C by DT-diaphorase.
Siegel D; Beall H; Senekowitsch C; Kasai M; Arai H; Gibson NW; Ross D
Biochemistry; 1992 Sep; 31(34):7879-85. PubMed ID: 1510975
[TBL] [Abstract][Full Text] [Related]
5. Sequence-selective alkylation and cross-linking induced by mitomycin C upon activation by DT-diaphorase.
Prakash AS; Beall H; Ross D; Gibson NW
Biochemistry; 1993 Jun; 32(21):5518-25. PubMed ID: 8504072
[TBL] [Abstract][Full Text] [Related]
6. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
[TBL] [Abstract][Full Text] [Related]
7. Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.
Paz MM; Ladwa S; Champeil E; Liu Y; Rockwell S; Boamah EK; Bargonetti J; Callahan J; Roach J; Tomasz M
Chem Res Toxicol; 2008 Dec; 21(12):2370-8. PubMed ID: 19053323
[TBL] [Abstract][Full Text] [Related]
8. Binding of 2,7-diaminomitosene to DNA: model for the precovalent recognition of DNA by activated mitomycin C.
Kumar GS; He QY; Behr-Ventura D; Tomasz M
Biochemistry; 1995 Feb; 34(8):2662-71. PubMed ID: 7873548
[TBL] [Abstract][Full Text] [Related]
9. Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase.
Maliepaard M; Wolfs A; Groot SE; de Mol NJ; Janssen LH
Br J Cancer; 1995 Apr; 71(4):836-9. PubMed ID: 7536024
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity.
Subramaniam G; Paz MM; Suresh Kumar G; Das A; Palom Y; Clement CC; Patel DJ; Tomasz M
Biochemistry; 2001 Sep; 40(35):10473-84. PubMed ID: 11523988
[TBL] [Abstract][Full Text] [Related]
11. Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.
Palom Y; Belcourt MF; Tang LQ; Mehta SS; Sartorelli AC; Pritsos CA; Pritsos KL; Rockwell S; Tomasz M
Biochem Pharmacol; 2001 Jun; 61(12):1517-29. PubMed ID: 11377381
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific delivery of a quinone methide intermediate to the major groove of DNA.
Zhou Q; Pande P; Johnson AE; Rokita SE
Bioorg Med Chem; 2001 Sep; 9(9):2347-54. PubMed ID: 11553475
[TBL] [Abstract][Full Text] [Related]
13. DNA alkylation by enzyme-activated mitomycin C.
Pan SS; Iracki T; Bachur NR
Mol Pharmacol; 1986 Jun; 29(6):622-8. PubMed ID: 3086708
[TBL] [Abstract][Full Text] [Related]
14. The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity.
Tomasz M; Palom Y
Pharmacol Ther; 1997; 76(1-3):73-87. PubMed ID: 9535170
[TBL] [Abstract][Full Text] [Related]
15. Structural and function modification of DNA by mitomycin C. Mechanism of the DNA sequence specificity of mitomycins.
Gargiulo D; Kumar GS; Musser SS; Tomasz M
Nucleic Acids Symp Ser; 1995; (34):169-70. PubMed ID: 8841606
[TBL] [Abstract][Full Text] [Related]
16. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Celli CM; Tran N; Knox R; Jaiswal AK
Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C linked to DNA minor groove binding agents: synthesis, reductive activation, DNA binding and cross-linking properties and in vitro antitumor activity.
Paz MM; Das TA; Tomasz M
Bioorg Med Chem; 1999 Dec; 7(12):2713-26. PubMed ID: 10658576
[TBL] [Abstract][Full Text] [Related]
18. Studies related to antitumor antibiotics. Part V. Reactions of mitomycin C with DNA examined by ethidium fluorescence assay.
Lown JW; Begleiter A; Johnson D; Morgan AR
Can J Biochem; 1976 Feb; 54(2):110-9. PubMed ID: 4201
[TBL] [Abstract][Full Text] [Related]
19. DNA adduct of the mitomycin C metabolite 2,7-diaminomitosene is a nontoxic and nonmutagenic DNA lesion in vitro and in vivo.
Utzat CD; Clement CC; Ramos LA; Das A; Tomasz M; Basu AK
Chem Res Toxicol; 2005 Feb; 18(2):213-23. PubMed ID: 15720125
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
